Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest ArticlesDeferasirox (Exjade) significantly improves cardiac T2* in heavily iron-overloaded patients with beta-thalassemia major
Annals of Hematology, 10/07/09
Pathare A et al. – Improvements were seen in patients with various degrees of cardiac siderosis, including those patients with a baseline cardiac T2* of <10 ms, indicative of high cardiac iron burden. These findings therefore support previous observations that deferasirox is effective in the removal of myocardial iron with concomitant reduction in total body iron.
Related Articles
Update on the use of deferasirox in the management of iron overload
Therapeutics and Clinical Risk Management, 11/05/09
Relevance Score: 89%
Effects of Chelators (Deferoxamine, Deferiprone and Deferasirox) on the Growth of Klebsiella Pneumoniae and Aeromonas Hydrophila Isolated from Transfusion-Dependent Thalassemia Patients
Hemoglobin, 10/23/09
Relevance Score: 82%
Adherence to Deferasirox in Children and Adolescents With Sickle Cell Disease During 1-year of Therapy
Journal of Pediatric Hematology/Oncology, 11/13/09
Relevance Score: 80%
A New Era in Iron Chelation Therapy: The Design of Optimal, Individually Adjusted Iron Chelation Therapies for the Complete Removal of Iron Overload in Thalassemia and other Chronically Transfused Patients
Hemoglobin, 10/23/09
Relevance Score: 80%
Risk/Benefit Assessment, Advantages Over Other Drugs and Targeting Methods in the Use of Deferiprone as a Pharmaceutical Antioxidant in Iron Loading and Non Iron Loading Conditions
Hemoglobin, 10/23/09
Relevance Score: 80%
Today in Anemia/Polycythemia...keeping you current
Receive free subspecialty "5-minute updates" via email
Unpredictability of iv Busulfan pharmacokinetics in children undergoing hematopoietic stem cell transplant for advanced beta thalassemia: Limited toxicity with a dose adjustment policy
Biology of Blood and Marrow Transplantation, 12/09/09
Molecular Analysis of gamma-Globin Promoters, HS-111 and 3'HS1, in beta-thalassemia Intermedia Patients Associated with High Levels of Hb F
Hemoglobin, 12/09/09
Molecular Characterization of a Novel 55.1 kb Ggamma(Agammadeltabeta)0-thalassemia Deletion in Two Canadian Families
Hemoglobin, 12/09/09
Today in Pharmacology/Therapy...keeping you current
Receive free subspecialty "5-minute updates" via email
A gene expression signature that predicts the therapeutic response of the basal-like breast cancer to neoadjuvant chemotherapy
Breast Cancer Research and Treatment, 12/09/09
A randomized, placebo-controlled trial (NCIC CTG MAP1) examining the effects of letrozole on mammographic breast density and other end organs in postmenopausal women
Breast Cancer Research and Treatment, 12/09/09
Relationship between exposure to sunitinib and efficacy and tolerability endpoints in patients with cancer: Results of a pharmacokinetic/pharmacodynamic meta-analysis
Cancer Chemotherapy and Pharmacology, 12/09/09
Sponsor
Article Search
Sponsor
Sponsor